Technology giant Microsoft (NASDAQ:MSFT) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up ...

Mirum Pharmaceuticals (NasdaqGM:MIRM) reported positive primary endpoint results from its Phase 2b AZURE-1 study of brelovitug in chronic hepatitis delta virus (HDV). The trial showed robust antiviral ...

On a recent episode of Thoughtful Money with Adam Taggart, 29-year-old investor Peter Slegers described how he tracks his ...

Microsoft and OpenAI’s amended deal loosens exclusivity, simplifies economics, and signals AI’s shift toward multi-cloud ...

This revenue achievement hides a structural discrepancy: current cyclical robustness in hardware is compensating for a ...

Microsoft is losing exclusive access to OpenAI's technology, clearing the way for the ChatGPT creator to sell its products across rival cloud platforms in a sweeping change to one of the artificial ...

We’re getting ever-closer to Dubai winter, meaning that days of cool breezes and gorgeous sunshine are right around the ...

Windrose hit early access earlier this month, and Bradford has been sailing the high seas in search of plunder. Here is his ...

Microsoft is set to report earnings Wednesday afternoon, with the stock seen potentially hitting its highest point in months ...

As communities continue to celebrate Earth Day, a growing number of consumers are looking for simple ways to cut down on ...

The traditional software playbook promised that more users meant better margins. Generative AI breaks that rule entirely; ...

This earnings cycle represents the first meaningful test of whether the AI trade can continue to justify elevated valuations ...